Form 4: TFS Financial CFO Sells 15,000 Shares in Pre-Planned Trade
Insider Trading Report
Meredith S. Weil, CFO and Director of TFS Financial Corp, reported the sale of 15,000 shares of common stock at $14.95 per share as part of a pre-arranged trading plan.
Summary
- Meredith S. Weil, Chief Financial Officer and Director of TFS Financial Corp (TFSL), sold a total of 15,000 shares of common stock.
- The sales occurred on February 11, 2026, at a price of $14.95 per share.
- The transactions were conducted under a Rule 10b5-1(c) pre-arranged trading plan.
- Following these transactions, Ms. Weil directly beneficially owns 52,236 shares of common stock.
- Additionally, Ms. Weil indirectly owns 379 shares via a 401(k) and 1,033 shares via an ESOP.
- Ms. Weil also holds various derivative securities, including 48,067 Restricted Stock Units, 12,700 Performance Restricted Share Units, and 241,900 Employee Stock Options.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While an insider sale reduces direct ownership, the pre-planned nature under Rule 10b5-1(c) mitigates concerns about negative sentiment, and the executive retains substantial equity exposure.
Positives
- The sale was executed under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not necessarily a reaction to new, negative information.
- Ms. Weil retains significant equity exposure through direct holdings, RSUs, PSUs, and stock options, aligning her interests with shareholders.
Negatives
- An insider sale, even if pre-planned, reduces the direct equity stake of a key executive in the company.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider sales, particularly by high-ranking executives like a CFO, are routinely monitored by investors for signals about management's confidence in the company's future. However, the indication that this sale was part of a Rule 10b5-1(c) plan suggests a pre-scheduled transaction for personal financial planning rather than a reaction to new, non-public information, which is a common practice among executives to manage their equity holdings.
Stakeholder Impact
- Shareholders: May interpret the sale as a slight reduction in insider confidence, though mitigated by the 10b5-1 plan. The executive's continued significant equity holdings still align interests.
Key Dates
| Date | Description |
|---|---|
| 2011-05-14 | First vesting installment for 3,600 restricted stock units granted on September 29, 2011. |
| 2011-09-29 | Grant date for 3,600 restricted stock units. |
| 2016-12-15 | Grant date for 79,400 employee stock options. |
| 2017-12-10 | First vesting installment for 79,400 employee stock options granted on December 15, 2016. |
| 2018-01-08 | Grant date for 187,500 employee stock options. |
| 2018-12-10 | First vesting installment for 187,500 employee stock options granted on January 8, 2018. |
| 2024-03-04 | Grant date for 14,400 Restricted Stock Units and initial award date for 12,700 Performance Share Units. |
| 2024-12-10 | First vesting installment for 14,400 Restricted Stock Units granted on March 4, 2024. |
| 2024-12-19 | Grant date for 16,600 Restricted Stock Units. |
| 2025-09-30 | End of two fiscal year performance period for Performance Share Units awarded on March 4, 2024. |
| 2025-11-25 | Determination date that reporting person achieved 100% performance level for 12,700 Performance Share Units. |
| 2025-12-10 | First vesting installment for 16,600 Restricted Stock Units granted on December 19, 2024. |
| 2025-12-18 | Grant date for 16,500 Restricted Stock Units. |
| 2026-02-11 | Date of common stock sales by Meredith S. Weil. |
| 2026-02-12 | Signature date of the Form 4 filing. |
| 2026-12-10 | First vesting installment for 16,500 Restricted Stock Units granted on December 18, 2025, and vesting/distribution date for 12,700 Performance Share Units. |
| 2026-12-15 | Expiration date for 54,400 employee stock options granted on December 15, 2016. |
| 2028-01-05 | Expiration date for 187,500 employee stock options granted on January 8, 2018. |
Recommendation
holdThe insider sale, while reducing direct ownership, was executed under a pre-planned Rule 10b5-1(c) program, which typically signals a non-discretionary transaction for personal financial management rather than a reaction to new company-specific information. The executive retains substantial equity exposure through direct shares, RSUs, PSUs, and stock options, maintaining alignment with shareholder interests. This filing alone does not present new information warranting a change in investment thesis.
Keywords
TFS Financial, TFSL, Insider Trading, Form 4, Stock Sale, Meredith S. Weil, CFO, Director, Equity Compensation, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.